Chaoting Zhang1, Rui Zhang1,2, Zhiqiang Chen1, Jing Chen1, Jigang Ruan1, Zheming Lu1, Hongchao Xiong1, Wenjun Yang1,2. 1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute, Beijing 100142, China. 2. Key Laboratory of Fertility Preservation and Maintenance, the School of Basic Medicine, the General Hospital, Ningxia Medical University, Yinchuan 750004, China.
Abstract
OBJECTIVE: This study aimed to comprehensively assess Epstein-Barr virus (EBV)-induced methylation alterations of B cell across whole genome. METHODS: We compared DNA methylation patterns of primary B cells and corresponding lymphoblastoid cell lines (LCLs) from eight participants. The genome-wide DNA methylation profiles were compared at over 850,000 genome-wide methylation sites. RESULTS: DNA methylation analysis revealed 87,732 differentially methylated CpG sites, representing approximately 12.41% of all sites in LCLs compared to primary B cells. The hypermethylated and hypomethylated CpG sites were about 22.75% or 77.25%, respectively. Only 0.8% of hypomethylated sites and 4.5% of hypermethylated sites were located in CpG islands, whereas 8.0% of hypomethylated sites and 16.3% of hypermethylated sites were located in shore (N_shore and S_shore). Using principal component analysis of the DNA methylation profiles, primary B cells and LCLs could be accurately predicted. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of differently methylated genes revealed that most of the top GO biological processes were related to cell activation and immune response, and some top enrichment pathways were related with activation and malignant transformation of human B cells. CONCLUSIONS: Our study demonstrated genome-wide DNA methylation variations between primary B cells and corresponding LCLs, which might yield new insight on the methylation mechanism of EBV-induced immortalization.
OBJECTIVE: This study aimed to comprehensively assess Epstein-Barr virus (EBV)-induced methylation alterations of B cell across whole genome. METHODS: We compared DNA methylation patterns of primary B cells and corresponding lymphoblastoid cell lines (LCLs) from eight participants. The genome-wide DNA methylation profiles were compared at over 850,000 genome-wide methylation sites. RESULTS: DNA methylation analysis revealed 87,732 differentially methylated CpG sites, representing approximately 12.41% of all sites in LCLs compared to primary B cells. The hypermethylated and hypomethylated CpG sites were about 22.75% or 77.25%, respectively. Only 0.8% of hypomethylated sites and 4.5% of hypermethylated sites were located in CpG islands, whereas 8.0% of hypomethylated sites and 16.3% of hypermethylated sites were located in shore (N_shore and S_shore). Using principal component analysis of the DNA methylation profiles, primary B cells and LCLs could be accurately predicted. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of differently methylated genes revealed that most of the top GO biological processes were related to cell activation and immune response, and some top enrichment pathways were related with activation and malignant transformation of human B cells. CONCLUSIONS: Our study demonstrated genome-wide DNA methylation variations between primary B cells and corresponding LCLs, which might yield new insight on the methylation mechanism of EBV-induced immortalization.
Entities:
Keywords:
B cells; DNA methylation; Epstein-Barr virus; LCLs; next generation sequencing
Authors: Xiangsheng Zuo; Min Xu; Jiang Yu; Yuanqing Wu; Micheline J Moussalli; Ganiraju C Manyam; Sun Il Lee; Shoudan Liang; Mihai Gagea; Jeffrey S Morris; Russell R Broaddus; Imad Shureiqi Journal: J Natl Cancer Inst Date: 2014-03-28 Impact factor: 13.506
Authors: Ondrej Havranek; Jingda Xu; Stefan Köhrer; Zhiqiang Wang; Lisa Becker; Justin M Comer; Jared Henderson; Wencai Ma; John Man Chun Ma; Jason R Westin; Dipanjan Ghosh; Nicholas Shinners; Luhong Sun; Allen F Yi; Anusha R Karri; Jan A Burger; Tomasz Zal; R Eric Davis Journal: Blood Date: 2017-06-23 Impact factor: 22.113
Authors: Alika K Maunakea; Raman P Nagarajan; Mikhail Bilenky; Tracy J Ballinger; Cletus D'Souza; Shaun D Fouse; Brett E Johnson; Chibo Hong; Cydney Nielsen; Yongjun Zhao; Gustavo Turecki; Allen Delaney; Richard Varhol; Nina Thiessen; Ksenya Shchors; Vivi M Heine; David H Rowitch; Xiaoyun Xing; Chris Fiore; Maximiliaan Schillebeeckx; Steven J M Jones; David Haussler; Marco A Marra; Martin Hirst; Ting Wang; Joseph F Costello Journal: Nature Date: 2010-07-08 Impact factor: 49.962
Authors: Kostas Paschos; Paul Smith; Emma Anderton; Jaap M Middeldorp; Robert E White; Martin J Allday Journal: PLoS Pathog Date: 2009-06-26 Impact factor: 6.823
Authors: Kasper D Hansen; Sarven Sabunciyan; Ben Langmead; Noemi Nagy; Rebecca Curley; Georg Klein; Eva Klein; Daniel Salamon; Andrew P Feinberg Journal: Genome Res Date: 2013-09-25 Impact factor: 9.043